Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Terminated 3 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 184 Carcinoma, Non-Small-Cell Lung 142 Multiple Myeloma 119 Prostatic Neoplasms 116 Colorectal Neoplasms 75 Leukemia, Myeloid, Acute 74 Neoplasms 73 Melanoma 71 Squamous Cell Carcinoma of Head and Neck 65 Lymphoma 64 Lung Neoplasms 64 Neoplasm Metastasis 63 Pancreatic Neoplasms 55 Ovarian Neoplasms 49 Sarcoma 45 Carcinoma, Renal Cell 45 Triple Negative Breast Neoplasms 42 Urinary Bladder Neoplasms 41 Leukemia, Lymphocytic, Chronic, B-Cell 41 Glioblastoma 41 Carcinoma, Hepatocellular 41 Recurrence 40 Head and Neck Neoplasms 37 Lymphoma, Large B-Cell, Diffuse 35 Brain Neoplasms 35 Myelodysplastic Syndromes 34 Hematologic Neoplasms 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Lymphoma, Non-Hodgkin 33 Lymphoma, Mantle-Cell 32

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Active not recruiting × Exanthema × Clear all

NCT06399029 2026-04-30

TRUX-LST

University of Zurich

Phase 2 Active not recruiting

Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡